 | Up a level |
Stickel, F; Helbling, B; Heim, M; Geier, A; Hirschi, C; Terziroli, B; Wehr, K; De Gottardi, A; Negro, F; Gerlach, T (2012). Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C. Journal of viral hepatitis, 19(2), pp. 77-87. Oxford: Blackwell Science 10.1111/j.1365-2893.2011.01527.x
Frei, P; Leucht, AK; Held, U; Kofmehl, R; Schmitt, J; Rau, M; Gerlach, T; Negro, F; Heim, MH; Moradpour, D; Cerny, A; Dufour, Jean-François; Mullhaupt, B; Geier, A (2011). Age Above 60 Years Is Not a Negative Predictive Factor For Combined Antiviral Therapy With Pegylated Interferon Alpha and Ribavirin in Hepatitis C Patients. Hepatology, 54(1), 826A-826A. Hoboken, N.J.: Wiley Interscience
Bochud, PY; Bibert, S; Kutalik, Z; Patin, E; Guergnon, J; Nalpas, B; Goossens, N; Kuske, L; Müllhaup, B; Gerlach, T; Heim, MH; Moradpour, D; Cerny, A; Malinverni, R; Regenass, S; Dollenmaier, G; Hirsch, H; Martinetti, G; Gorgiewski, M; Boulière, M; ... (2011). Swiss Hepatitis C Cohort Study Grp. IL28B Polymorphisms Linked to Poor Response To Treatment are Associated with Low Necroinflammatory Activity and Slow Fibrosis Progression in HCV Genotype Non-1-Infected patientsBern. Hepatology, 54(1), p. 539. Hoboken, N.J.: Wiley Interscience 10.1016/S0168-8278(11)61363-9
Sgier, C; Müllhaupt, B; Gerlach, T; Moradpour, D; Negro, F; Malé, PJ; Heim, MH; Malinverni, R; Cerny, A (2010). Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C. Journal of viral hepatitis, 17(12), pp. 845-850. Oxford: Blackwell Science 10.1111/j.1365-2893.2009.01251.x
